Helius Medical Technologies saw its shares soar over 200% following a $10 million investment from Sino-High Technology, a Hong Kong-listed firm. This marks Sino-High's inaugural investment under its $500 million DAT Special Plan, aimed at digital asset treasury projects. Helius, listed on NASDAQ, announced a strategic transformation into a SOL treasury company, which fueled the stock's pre-market gains of up to 270%. Prior to this, Helius shares closed at $7.56, with a market cap of $8.14 million. Sino-High plans to reveal its next investment project soon.